Alpiq and aventron have signed a power purchase agreement (PPA) in Italy with global pharmaceutical Chiesi Group to supply emission-free energy from a local wind power plant.
The two-year contract ensures sustainable energy supply to Chiesi Group from aventron’s 18MW Italian wind power plant. The asset is located in the Basilicata region in Southern Italy and avoids 23,400 tons of CO2 emissions per year. This agreement is a key milestone on the Italian market for all parties.
The project facilitates the commercial integration of renewable energy into the Italian power market and aligns with Cheisi’s recently released plan to be carbon neutral by 2030 on direct greenhouse gas (GHG) emissions, and indirect GHG emissions from purchased electricity and heat (scope 1 and 2) and by 2035.
Said Ugo Di Francesco, CEO of Chiesi Group: “Companies should be held accountable for delivering on their commitments and society should not forget the promises made. This is why we want to commit to things that can be measured, and we dare to share our progress publicly. With this campaign, we invite all our peers to join us on this path.”
Aventron is significantly expanding electricity production from wind power. Over the next few months, 28MW of additional wind power capacity in Germany, France and Norway will be connected to the grid.
Present in Italy since 1999, Alpiq operates its own gas-fired combined cycle power plants in Vercelli, Novara and San Severo as well as wind and photovoltaic farms in Sicily and small-scale hydropower plants in Piedmont.